Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Brixner

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Journal of Health Economics and Outcomes Research|April 1, 2024
The Association of Retinal Disease with Vision Impairment and Functional Status in Medicare PatientsVincent Garmo, Xiaohui Zhao, Carmen D Ng, et al.
Leukemia Research|November 23, 2019
Clinical and economic analysis of patients with acute myeloid leukemia by FLT3 status and midostaurin use at a Comprehensive Cancer CenterConnor Willis, Jyothi Menon, Sudhir Unni, et al.
Journal of Managed Care & Specialty Pharmacy|July 1, 2024
Clinical characteristics and treatment patterns of patients with <i>NTRK</i> fusion-positive solid tumors: A multisite cohort study at US academic cancer centersConnor Willis, Trang Au, Andre Hejazi, et al.
Cancer Treatment and Research Communications|March 22, 2025
Real-world comparative outcomes of EGFR-TKIs for first-line treatment of EGFR+ metastatic non-small-cell lung cancerKibum Kim, Sakil Syeed, Trang Au, et al.
Journal of Comparative Effectiveness Research|October 23, 2015
Systematic overview of cost-effectiveness thresholds in ten countries across four continentsRuth Schwarzer, Ursula Rochau, Kim Saverno, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest GroupEric Faulkner, Anke-Peggy Holtorf, Surrey Walton, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2025
Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021Janna Manjelievskaia, Viral N Shah, Anders L Carlson, et al.
Oncotarget|December 6, 2022
Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. studyConnor Willis, Hillevi Bauer, Trang H Au, et al.
Oncotarget|February 3, 2022
Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. studyConnor Willis, Hillevi Bauer, Trang H Au, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 18, 2021
Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastomaTrang H Au, Connor Willis, Maija Reblin, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Journal of Health Economics and Outcomes Research|April 1, 2024
The Association of Retinal Disease with Vision Impairment and Functional Status in Medicare PatientsVincent Garmo, Xiaohui Zhao, Carmen D Ng, et al.
Leukemia Research|November 23, 2019
Clinical and economic analysis of patients with acute myeloid leukemia by FLT3 status and midostaurin use at a Comprehensive Cancer CenterConnor Willis, Jyothi Menon, Sudhir Unni, et al.
Journal of Managed Care & Specialty Pharmacy|July 1, 2024
Clinical characteristics and treatment patterns of patients with <i>NTRK</i> fusion-positive solid tumors: A multisite cohort study at US academic cancer centersConnor Willis, Trang Au, Andre Hejazi, et al.
Cancer Treatment and Research Communications|March 22, 2025
Real-world comparative outcomes of EGFR-TKIs for first-line treatment of EGFR+ metastatic non-small-cell lung cancerKibum Kim, Sakil Syeed, Trang Au, et al.
Journal of Comparative Effectiveness Research|October 23, 2015
Systematic overview of cost-effectiveness thresholds in ten countries across four continentsRuth Schwarzer, Ursula Rochau, Kim Saverno, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest GroupEric Faulkner, Anke-Peggy Holtorf, Surrey Walton, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2025
Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021Janna Manjelievskaia, Viral N Shah, Anders L Carlson, et al.
Oncotarget|December 6, 2022
Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. studyConnor Willis, Hillevi Bauer, Trang H Au, et al.
Oncotarget|February 3, 2022
Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. studyConnor Willis, Hillevi Bauer, Trang H Au, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 18, 2021
Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastomaTrang H Au, Connor Willis, Maija Reblin, et al.
Pageof 11